Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2010
03/18/2010WO2010007382A8 Benzazepine derivatives and their use as hstamine h3 antagonists
03/18/2010WO2010006973A3 Compositions and methods for inhibiting expression of tgf-beta receptor genes
03/18/2010WO2010006392A3 Pharmaceutical composition comprising jasmonates
03/18/2010WO2010005735A3 Compositions for inducing immune responses specific to globo h and ssea3 and uses thereof in cancer treatment
03/18/2010WO2010003601A8 Pharmaceutical compositions based on kinin b2 receptor antagonists and corticosteroids, and their use
03/18/2010WO2010003133A3 Cdk modulators
03/18/2010WO2009156863A3 Substituted tricyclic derivatives against neurodegenerative diseases
03/18/2010WO2009155139A9 Use of isoindoles for the treatment of neurobehavioral disorders
03/18/2010WO2009155116A9 Methods of reducing pain and inflammation
03/18/2010WO2009154697A3 Disc-1 pathway activators in the control of neurogenesis
03/18/2010WO2009152500A3 Methods and compositions for mediating gene silencing
03/18/2010WO2009152430A3 Methods of treatment of bipolar disorder
03/18/2010WO2009152168A3 Carboxylic acid salts of 2-amino-3-carbethoxyamino-6-(4-fluoro-benzylamino)-pyridine
03/18/2010WO2009147684A3 Compositions and methods for treatment of ear disorders
03/18/2010WO2009147178A3 Substituted pyridin-2-ylmethylsulphinyl-1h-benzimidaz0les for use in the treatment of brain edema
03/18/2010WO2009146216A3 Antioxidant inflammation modulators: novel derivatives of oleanolic acid
03/18/2010WO2009145996A3 Amide derivatives as positive allosteric modulators and methods of use thereof
03/18/2010WO2009141826A3 Novel conjugates of polymers having a therapeutically active agent and an angiogenesis targeting moiety attached thereto and uses thereof in the treatment of angiogenesis related diseases
03/18/2010WO2009141823A3 Conjugates of a polymer, a bisphosphonate and an anti-angiogenesis agent and uses thereof in the treatment and monitoring of bone related diseases
03/18/2010WO2009140137A9 Naphthylmethylimidizoles for the treatment of stress urinary incontinence
03/18/2010WO2009139939A3 Hybrid nanoparticles as anti-cancer therapeutic agents and dual therapeutic/imaging contrast agents
03/18/2010WO2009138170A3 Film-shaped preparation comprising oily substances for oral administration
03/18/2010WO2009137714A3 Forms of lapatinib ditosylate and processes for preparation thereof
03/18/2010WO2009136979A3 Compounds that modulate negative-sense, single-stranded rna virus replication and uses thereof
03/18/2010WO2009134616A3 Novel inhibitors of hepatitis c virus replication
03/18/2010WO2009133071A3 Polyelectrolyte with positive net charge for use as medicament and diagnostic for cancer
03/18/2010WO2009132149A3 Treatment of conditions related to cecal ligation shock
03/18/2010WO2009131974A8 Thiophenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as bace-1 inhibitors, compositions, and their use
03/18/2010WO2009129464A4 Method for treating acute pain with a formulated drug depot in combination with a liquid formulation
03/18/2010WO2009129456A4 Alpha adrenergic receptor agonists for treatment of inflammatory diseases
03/18/2010WO2009129439A4 Medical devices and methods including polymers having biologically active agents therein
03/18/2010WO2009129432A4 Alpha adrenergic receptor agonists for treatment of pain and/or inflammation
03/18/2010WO2009129305A3 Prodrugs of neuraminidase inhibitors
03/18/2010WO2009126931A3 Therapy for bipolar disorder and mania with buprenorphine
03/18/2010WO2009126806A3 Thiazolopyridin-2-yloxy-phenyl and thiazolopyrazin-2-yloxy-phenyl amines as modulators of leukotriene a4 hydrolase
03/18/2010WO2009124723A9 Novel aureothin derivatives
03/18/2010WO2009114118A3 Oral pharmaceutical compositions of buprenorphine and method of use
03/18/2010WO2009099507A3 Treating oncogenic ras driven cancers
03/18/2010WO2009095923A3 Corroles for neuroprotection and neurorescue
03/18/2010WO2009095395A3 Pharmaceutical compositions
03/18/2010WO2009082448A3 Modified oligonucleotides for the treatment of hepatitis c infection
03/18/2010WO2009079066A3 Therapeutic and vaccine polyelectrolyte nanoparticle compositions
03/18/2010WO2009077573A3 Suspension comprising non-micronized ezetimibe micro-particles
03/18/2010WO2009064389A3 Smart hydrogel particles: biomarker harvesting: one-step affinity purification, size exclusion, and protection against degradation
03/18/2010WO2009063320A3 Solid pharmaceutical composition of ded anosine
03/18/2010WO2009061395A3 Hcv combination therapies comprising vx-950, peg-ifn and ribavirin
03/18/2010WO2009056707A8 Indol-2-one derivatives disubstituted in the 3-position, preparation thereof and therapeutic use thereof
03/18/2010WO2009018185A3 Ectoparasite control method
03/18/2010WO2009004164A9 Diazeniumdiolate derivatives, method for preparing same and pharmaceutical compositions containing same
03/18/2010WO2009000909A3 Salts of perindopril
03/18/2010WO2008154898A3 Preparation for the treatment of equine laminitis
03/18/2010WO2008144453A9 Methods of treating cognitive disorders by inhibition of gpr12
03/18/2010WO2008139313A8 Propofol transparent anaesthetic solution with low venous irritation
03/18/2010US20100071078 Rspondins as modulators of angiogenesis and vasculogenesis
03/18/2010US20100069938 Glaucoma surgery
03/18/2010US20100069877 Apparatus and method to dispense hpc-based viscous liquids into porous substrates, e.g., continuous web-based process
03/18/2010US20100069504 Aminobenzocycloheptene derivatives, methods for preparing the same and uses thereof in therapy
03/18/2010US20100069503 Inhibition of mitogen-activated protein kinases in cardiovascular disease
03/18/2010US20100069502 Assay
03/18/2010US20100069501 Pharmaceutical Composition Comprising 6-Dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol and Paracetamol
03/18/2010US20100069500 Amide dendrimer compositions
03/18/2010US20100069498 Use of alpha-ketoglutaric acid for the treatment of high plasma glucose condition
03/18/2010US20100069496 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
03/18/2010US20100069495 Topical application of adapalene for the long-term treatment of acne vulgaris
03/18/2010US20100069494 Lowering of proteins associated with alzheimer's disease by interrupting gene transcription with a small molecule
03/18/2010US20100069493 Aqueous pharmaceutical formulation of 4-[((4-carboxybutyl)-amino)methyl]benzoic acid
03/18/2010US20100069492 Production of ultrapure epa and polar lipids from largely heterotrophic culture
03/18/2010US20100069491 Lipid-amino acid conjugates and methods of use
03/18/2010US20100069490 Composition for a pharmaceutical treatment based on triethyl citrate and adapalene
03/18/2010US20100069489 L-threonine derivatives of high therapeutic index
03/18/2010US20100069487 Method for the treatment of psoriasis
03/18/2010US20100069486 Anti-tumor composition
03/18/2010US20100069485 Method for maintaining freshness of fruits and vegetables
03/18/2010US20100069484 SIGMA(s)-RECEPTOR LIGANDS WITH ANTI-APOPTOTIC AND/OR PRO-APOPTOTIC PROPERTIES OVER CELLULAR BIOCHEMICAL MECHANISMS, WITH NEUROPROTECTIVE, ANTI-CANCER, ANTI-METASTATIC AND ANTI-(CHRONIC) INFLAMMATORY ACTION
03/18/2010US20100069483 Dual inhibition of cyclooxygenase-2 and carbonic anhydrase
03/18/2010US20100069482 Gel useful for the delivery of ophthalmic drugs
03/18/2010US20100069481 Methods and compositions for the treatment of cancer
03/18/2010US20100069480 Methods and compositions for the treatment of cancer
03/18/2010US20100069479 Neurodegenerative disease treatment using jak/stat inhibition
03/18/2010US20100069478 Isoflavone derivatives and uses thereof
03/18/2010US20100069477 Methioninase inhibitor and composition and food or drink containing the same
03/18/2010US20100069476 Compositions and methods for reduction of cutaneous photoageing
03/18/2010US20100069475 Method of activating nk cells
03/18/2010US20100069474 Novel coumarin derivatives as ion channel openers
03/18/2010US20100069473 Inhibitors Of IKK-Beta Serine-Threonine Protein Kinase
03/18/2010US20100069472 Compositions and their uses directed to huntingtin
03/18/2010US20100069471 Chemically modified oligonucleotides
03/18/2010US20100069470 Identification of protein biomarkers associated with lymph node metastasis in colorectal cancer
03/18/2010US20100069469 Formulations and composites with reactive fillers
03/18/2010US20100069468 Inhibition of beta-amyloid peptide aggregation
03/18/2010US20100069467 Double-stranded/self-complementary vectors with a truncated cba promoter and methods of gene delivery
03/18/2010US20100069465 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
03/18/2010US20100069464 Compositions and methods for modulating activity of capped small rnas
03/18/2010US20100069463 Methods for the diagnosis and treatment of affective disorders and cushing's syndromes
03/18/2010US20100069462 Mitochondrial function of prohibitin 2 (phb2)
03/18/2010US20100069461 Compositions and methods for inhibiting expression of factor v leiden mutant gene
03/18/2010US20100069460 1-phenyl 1-thio-d-glucitol derivative
03/18/2010US20100069459 Novel forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid magnesium
03/18/2010US20100069458 Combination of lbh589 with other therapeutic agents for treating cancer
03/18/2010US20100069457 Naphthalene Derivatives Used As EP4 Receptor Agonists
1 ... 2344 2345 2346 2347 2348 2349 2350 2351 2352 2353 2354 2355 2356 2357 2358 2359 2360 2361 2362 2363 2364 ... 7860